Logo image of NUV

NUVEEN MUNICIPAL VALUE (NUV) Stock Price, Quote, News and Overview

NYSE:NUV - New York Stock Exchange, Inc. - US6709281009 - Currency: USD

8.56  +0.06 (+0.71%)

Fundamental Rating

3

Overall NUV gets a fundamental rating of 3 out of 10. We evaluated NUV against 0 industry peers in the Unkown industry. NUV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NUV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NUV was profitable.
NUV had positive earnings in 4 of the past 5 years.
NUV had a negative operating cash flow in each of the past 5 years.
NUV Yearly Net Income VS EBIT VS OCF VS FCFNUV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Industry RankSector Rank
ROA 3%
ROE 3.04%
ROIC 3.12%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NUV Yearly ROA, ROE, ROICNUV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15

1.3 Margins

In the last couple of years the Profit Margin of NUV has grown nicely.
NUV's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of NUV has remained more or less at the same level.
Industry RankSector Rank
OM 87.61%
PM (TTM) 66.8%
GM 98.86%
OM growth 3Y-0.44%
OM growth 5Y-0.22%
PM growth 3Y23.7%
PM growth 5Y21.6%
GM growth 3Y-0.37%
GM growth 5Y-0.1%
NUV Yearly Profit, Operating, Gross MarginsNUV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

More info and screens

4

2. Health

2.1 Basic Checks

NUV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NUV Yearly Shares OutstandingNUV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
NUV Yearly Total Debt VS Total AssetsNUV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

NUV has an Altman-Z score of 37.30. This indicates that NUV is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that NUV is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 37.3
ROIC/WACCN/A
WACCN/A
NUV Yearly LT Debt VS Equity VS FCFNUV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.3 Liquidity

NUV has a Current Ratio of 5.22. This indicates that NUV is financially healthy and has no problem in meeting its short term obligations.
NUV has a Quick Ratio of 5.22. This indicates that NUV is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 5.22
Quick Ratio 5.22
NUV Yearly Current Assets VS Current LiabilitesNUV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

NUV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 117.62%, which is quite impressive.
Measured over the past years, NUV shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.01% on average per year.
The Revenue has been growing slightly by 4.83% in the past year.
The Revenue has been decreasing by -0.65% on average over the past years.
EPS 1Y (TTM)117.62%
EPS 3Y25.13%
EPS 5Y21.01%
EPS Q2Q%15.38%
Revenue 1Y (TTM)4.83%
Revenue growth 3Y1.01%
Revenue growth 5Y-0.65%
Sales Q2Q%5.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUV Yearly Revenue VS EstimatesNUV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NUV is valuated quite expensively with a Price/Earnings ratio of 31.70.
Compared to an average S&P500 Price/Earnings ratio of 26.25, NUV is valued a bit more expensive.
Industry RankSector Rank
PE 31.7
Fwd PE N/A
NUV Price Earnings VS Forward Price EarningsNUV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUV Per share dataNUV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.51
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

NUV has a Yearly Dividend Yield of 4.04%, which is a nice return.
NUV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.04%

5.2 History

NUV has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of NUV decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
NUV Yearly Dividends per shareNUV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NUV Yearly Income VS Free CF VS DividendNUV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

More info and screens

NUVEEN MUNICIPAL VALUE

NYSE:NUV (5/30/2025, 8:21:09 PM)

8.56

+0.06 (+0.71%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)01-06 2025-01-06
Earnings (Next)06-30 2025-06-30
Inst Owners26.96%
Inst Owner Change-0.79%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.78B
Analysts45
Price TargetN/A
Short Float %0.16%
Short Ratio0.64
Dividend
Industry RankSector Rank
Dividend Yield 4.04%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-Date05-15 2025-05-15 (0.0325)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 31.7
Fwd PE N/A
P/S 21.6
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)0.27
EY3.15%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.4
BVpS8.69
TBVpS8.69
PEG (NY)N/A
PEG (5Y)1.51
Profitability
Industry RankSector Rank
ROA 3%
ROE 3.04%
ROCE 3.95%
ROIC 3.12%
ROICexc 3.14%
ROICexgc 3.14%
OM 87.61%
PM (TTM) 66.8%
GM 98.86%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.44%
OM growth 5Y-0.22%
PM growth 3Y23.7%
PM growth 5Y21.6%
GM growth 3Y-0.37%
GM growth 5Y-0.1%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.22
Quick Ratio 5.22
Altman-Z 37.3
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.62%
EPS 3Y25.13%
EPS 5Y21.01%
EPS Q2Q%15.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.83%
Revenue growth 3Y1.01%
Revenue growth 5Y-0.65%
Sales Q2Q%5.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.29%
EBIT growth 3Y0.56%
EBIT growth 5Y-0.87%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A